Patients with rheumatoid arthritis and cancer seek clear information on drug safety, cancer risks, and treatment decisions, a ...

Discover a recent report that states that, although GLP-1 medicines are generally well tolerated, there have been cases of ...

A groundbreaking multinational clinical trial, named RESILIENCE, is underway to test a promising new treatment aimed at ...

Rising one place to number one overall, the British drugmaker has overtaken the NHS as the preferred destination for science ...

Patients with functional anorectal pain show abnormal anal pressures, rectal hypersensitivity, and high rates of anxiety and ...

Fatigue scores may substitute for missing data in spondyloarthritis registries, but pain and global assessments should be ...

Phase 2b data show olorofim effective against resistant IFD, including azole-resistant fungi, with a favourable safety profile.

A blood test taken in the first trimester could identify women at risk of preeclampsia months before clinical signs emerge, ...

Stefan Oelrich is elected EFPIA President, as new leadership calls for action to restore Europe’s global leadership in pharma ...

Techniques like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are increasingly recommended to guide ...

Food allergies affect up to 10% of the population in the USA and have been increasing in prevalence over the last 2–3 ...

ESHRE 2025 study links advanced paternal age to increased miscarriage risk and lower live birth rates in donor egg IVF cycles ...